(888) 552-6760 SCHEDULE AN APPOINTMENT

Lauren Antrim,

Medical Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Education
Medical school:
Degree
  • 2019, Doctor of Medicine, Weill Cornell Medical College, New York, New York
Fellowship
  • 2024, Medical Oncology, John Hopkins University, Baltimore, Maryland
Residency
  • 2022, Internal Medicine, University of Southern California, Los Angeles, California
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
About Me

Lauren Antrim, M.D., is an assistant clinical professor of medical oncology and therapeutics research at City of Hope® Cancer Center Duarte. Her work focuses on developing personalized treatment plans for patients with complex lung cancer diagnoses and conducting leading-edge research into new therapies and approaches into novel therapies and treatment paradigms.

Dr. Antrim attended Weill Cornell Medical College in New York City. During that time, she also worked at a genomics lab in Spain, taking part in a study evaluating tumor drivers in triple-negative breast cancer. She completed her residency in internal medicine at the University of Southern California (USC) in Los Angeles, followed by a fellowship in medical oncology at Johns Hopkins University in Baltimore, Maryland.

Dr. Antrim has published multiple papers in her field and been a co-investigator on studies at both USC and at the University of California Riverside. 

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.